Skip to main content

Advertisement

SpringerLink
Log in

Axillary Management: How Has Neoadjuvant Chemotherapy Changed Our Surgical Approach?

  • Clinical Trial Report
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391–8.

    Article  CAS  Google Scholar 

  2. Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC. Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes. Ann Surg Oncol. 2018;25:2241–8.

    Article  Google Scholar 

  3. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 Randomised Phase III Trial. Lancet Oncol. 2007;8:881–8.

    Article  CAS  Google Scholar 

  4. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927–33.

    Article  Google Scholar 

  5. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569–75.

    Article  CAS  Google Scholar 

  6. Geng C, Chen X, Pan X, Li J. The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis. PLoS One. 2016;11:e0162605.

    Article  Google Scholar 

  7. Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455–61.

    Article  CAS  Google Scholar 

  8. Boughey JC, Ballman KV, Le-Petross HT, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0–T4, N1–N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (Alliance). Ann Surg. 2016;263:802–7.

    Article  Google Scholar 

  9. Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18.

    Article  Google Scholar 

  10. Boileau J-F, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. J Clin Oncol. 2015;33:258–64.

    Article  Google Scholar 

  11. McCready DR, Yong WS, Ng ATK, Miller N, Done S, Youngson B, et al. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J Natl Cancer Inst. 2004;96:873–5.

    Article  Google Scholar 

  12. Classe J-M, Loaec C, Gimbergues P, et al. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat. 2019;173:343–52.

    Article  Google Scholar 

  13. Moo T-A, Edelweiss M, Hajiyeva S, et al. Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection? Ann Surg Oncol. 2018;25(6):1488–94.

    Article  Google Scholar 

  14. Moo T-A, Jochelson MS, Zabor EC, et al. Is clinical exam of the axilla sufficient to select node-positive patients who downstage after NAC for SLNB? A comparison of the accuracy of clinical exam versus MRI. Ann Surg Oncol. 2019;26:4238–43.

    Article  Google Scholar 

  15. Boughey JC, Ballman KV, Hunt KK, et al. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol. 2015;33:3386–93.

    Article  CAS  Google Scholar 

  16. Boughey JC, Suman VJ, Mittendorf EA, et al. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg. 2015;261:547–52.

    Article  Google Scholar 

  17. Diego EJ, McAuliffe PF, Soran A, et al. Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes. Ann Surg Oncol. 2016;23:1549–53.

    Article  Google Scholar 

  18. Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34:1072–8.

    Article  CAS  Google Scholar 

  19. Donker M, Straver ME, Wesseling J, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. 2015;261:378–82.

    Article  Google Scholar 

  20. Park S, Koo JS, Kim GM, et al. Feasibility of charcoal tattooing of cytology-proven metastatic axillary lymph node at diagnosis and sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients. Cancer Res Treat. 2018;50:801–12.

    Article  CAS  Google Scholar 

  21. Plecha D, Bai S, Patterson H, Thompson C, Shenk R. Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes. Ann Surg Oncol. 2015;22:4241–6.

    Article  Google Scholar 

  22. Trinh L, Miyake KK, Dirbas FM, et al. CT-guided wire localization for involved axillary lymph nodes after neo-adjuvant chemotherapy in patients with initially node-positive breast cancer. Breast J. 2016;22:390–6.

    Article  Google Scholar 

  23. Lim GH, Teo SY, Gudi M, et al. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: skin mark clipped axillary nodes removal technique (SMART trial). Cancer Med. 2020;9:1978–85.

    Article  CAS  Google Scholar 

  24. Hartmann S, Kühn T, de Boniface J, et al. Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial, Br J Surg 2021;108(3):302–7. https://doi.org/10.1093/bjs/znaa083.

  25. Galimberti V, Ribeiro Fontana SK, Maisonneuve P, et al. Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Eur J Surg Oncol. 2016;42:361–8.

    Article  CAS  Google Scholar 

  26. Martelli G, Miceli R, Folli S, et al. Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: long-term results of a retrospective study. Eur J Surg Oncol. 2017;43:2012–20.

    Article  CAS  Google Scholar 

  27. NRG. A randomized phase III clinical trial evaluating post-mastectomy chestwall and regional nodal XRT and post-lumpectomy regional nodal XRT in patients with positive axillary nodes before neoadjuvant chemotherapy who convert to pathologically negative axillary nodes after neoadjuvant chemotherapy (NSABP B-51 RTOG 1304) https://www.nrgoncology.org/Clinical-Trials/Protocol/nsabp-b-51-rtog-1304?filter=nsabp-b-51-rtog-1304. Accessed 22 January 2021.

  28. Mamounas EP, Bandos H, White JR, et al. NRG oncology/NSABP B-51/RTOG 1304: phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of rnrt to whole breast rt post breast-conserving Surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC). J Clin Oncol 2019;37:15_suppl.

  29. NIH. Comparison of axillary lymph node dissection with axillary radiation for patients with node-positive breast cancer treated with chemotherapy (Alliance A011202). https://clinicaltrials.gov/ct2/show/NCT01901094. Accessed 16 January 2021.

  30. Rutgers EJ, Donker M, Poncet C, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981/22023). In: SABCS 2018; San Antonio, TX. https://doi.org/10.1158/1538-7445.SABCS18-GS4-01.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA

    Mara A. Piltin & Judy C. Boughey

Authors
  1. Mara A. Piltin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judy C. Boughey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judy C. Boughey.

Ethics declarations

Conflict of Interest

Judy Boughey reports grants from NCI, during the conduct of the study; other from Eli Lilly, outside the submitted work. Mara Piltin declares no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piltin, M.A., Boughey, J.C. Axillary Management: How Has Neoadjuvant Chemotherapy Changed Our Surgical Approach?. Curr Breast Cancer Rep 14, 1–7 (2022). https://doi.org/10.1007/s12609-022-00442-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-022-00442-6

Search

Navigation